Replies to post #40740 on Latteno Food Corp (fka LATF)

[IBurnPurpleKush]

LATF,DLGI,HESG,SETY, AND KALCO HOLDINGS connections part 1


GO TO PAGE 8 OF THIS FILLING FOR LATF

http://www.otcmarkets.com/financialReportViewer?symbol=LATF&id=97999

Latteno Food Corp. (the “Company”) was incorporated in the state of Colorado on August 24, 1994 as Reii Incorporated. The Company remained dormant until October 16, 2000 when its name was changed to
iGoHealthy.com, Inc. On September 10, 2001, the Company changed its name to Latteno Food Corp.
Latteno Food Corp. is an integrated provider of innovative, science-based products and ingredients to
customers in the nutrition, skin care, and food and beverage industries. In June 2005, the Company
reincorporated in the state of Delaware and in February 2009, the company reincorporated in the State of

Florida.Effective December 14, 2001, the Company acquired 100% of the outstanding stock of XCEL Medical
Pharmacy, Inc., a California corporation (“XCEL”) and the outstanding shares of BioSelect Innovations,
Inc., a Nevada corporation (“BioSelect”) for approximately $4.4 million.

On February 25, 2003, effective January 1, 2003, the Company completed its acquisition of Quality
Botanical Ingredients, Inc. (“QBI”) pursuant to an Asset Purchase Agreement for approximately $1.5
million. QBI was a manufacturer and contract processor of bulk botanical materials and nutritional
ingredients supplied to buyers in various industries including pharmaceutical, nutraceutical and cosmetics.

On October 20, 2004, the Board of Directors of the Company elected to discontinue operations of its wholly
owned subsidiary, QBI. The Company, through the secured lender, engaged professional service firms to
facilitate the liquidation of QBI’s inventory and fixed assets and to collect QBI’s outstanding accounts
receivable. Proceeds from the sale of such assets will be used to repay QBI’s creditors for outstanding
obligations. The Company is a co-guarantor of the obligations of QBI pursuant to a Continuing
Unconditional Corporate Guaranty dated as of February 21, 2003. Management believes the Company’s
continuing operations will not be adversely affected by this action.

In May 2005, management determined that its pharmaceutical operations, XCEL, were inconsistent with the
Company’s revised strategic direction of identifying, developing and commercializing nutritional products
and functional food ingredients and therefore elected to discontinue operations.

In December 2004, the Company, through its newly formed subsidiary Swiss Research, a Delaware
corporation, (“Swiss Research”), initiated an agreement to acquire the assets of Swiss Research, a California
corporation, for cash and performance based warrants. Swiss Research is a diet and nutrition products
company which markets and sells Shugr, a zero-calorie and diabetic safe sugar substitute with the look, taste
and baking qualities of cane sugar. The agreement was executed in August 2005.





NOW THIS IS HESG'S FILLINGS... GO TO PAGE 10 UNDER NOTE 1

http://www.sec.gov/Archives/edgar/data/1127696/000101968706002873/hesg_10qsb-093006.htm



Health Sciences Group, Inc. (the “Company”) was incorporated in the state of Colorado on June 13, 1996 as Centurion Properties Development Corporation. The Company remained dormant until October 16, 2000 when its name was changed to iGoHealthy.com, Inc. On September 10, 2001, the Company changed its name to Health Sciences Group, Inc. Health Sciences Group, Inc. is an integrated provider of innovative, science-based products and ingredients to customers in the nutrition, skin care, and food and beverage industries. In June 2005, the Company reincorporated in the state of Delaware.


Effective December 14, 2001, the Company acquired 100% of the outstanding stock of XCEL Medical Pharmacy, Inc., a California corporation (“XCEL”) and the outstanding shares of BioSelect Innovations, Inc., a Nevada corporation (“BioSelect”) for approximately $4.4 million.

On February 25, 2003, effective January 1, 2003, the Company completed its acquisition of Quality Botanical Ingredients, Inc. (“QBI”) pursuant to an Asset Purchase Agreement for approximately $1.5 million. QBI was a manufacturer and contract processor of bulk botanical materials and nutritional ingredients supplied to buyers in various industries including pharmaceutical, nutraceutical and cosmetics. On October 20, 2004, the Board of Directors of the Company elected to discontinue operations of its wholly owned subsidiary, QBI (see Note 4). The Company, through the secured lender, engaged professional service firms to facilitate the liquidation of QBI’s inventory and fixed assets and to collect QBI’s outstanding accounts receivable. Proceeds from the sale of such assets will be used to repay QBI’s creditors for outstanding obligations. The Company is a co-guarantor of the obligations of QBI pursuant to a Continuing Unconditional Corporate Guaranty dated as of February 21, 2003. Management believes the Company’s continuing operations will not be adversely affected by this action.

In May 2005, management determined that its pharmaceutical operations, XCEL, were inconsistent with the Company’s revised strategic direction of identifying, developing and commercializing nutritional products and functional food ingredients and therefore elected to discontinue operations (see Note 4).

In December 2004, the Company, through its newly formed subsidiary Swiss Research, a Delaware corporation, (“Swiss Research”), initiated an agreement to acquire the assets of Swiss Research, a California corporation, for cash and performance based warrants. Swiss Research is a diet and nutrition products company which markets and sells Shugr, a zero-calorie and diabetic safe sugar substitute with the look, taste and baking qualities of cane sugar. The agreement was executed in August 2005.